Indication
COVID-19 with Respiratory Failure
2 clinical trials
3 products
Clinical trial
ZYESAMI (Aviptadil) for the Treatment of Critical COVID-19 With Respiratory FailureStatus: Completed, Estimated PCD: 2021-02-22
Product
AviptadilProduct
Normal SalineProduct
ZYESAMI